Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...

In this example, you use an XML Path Language (XPath) expression to address a dedicated element of your inbound message. XPath allows you to address any element in an XML structure by using a ...